Wuhan Jinyintan Hospital, Wuhan, China Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2020
NCT04276987
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Jin Yin-tan Hospital | Wuhan Jinyintan Hospital, Wuhan, China | Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)

Active Ingredients

Drugs in Phase 2 Trials (1)

umbilical cord mesenchymal stem cells (1 trial)

Drugs in Phase 1 Trials (2)

bacille calmette-guerin (1 trial)

exosomes from mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 1)

Pneumonia (Phase 1)

Tuberculosis (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3